| Wissenschaftl. Titel | An Open-Label, Phase 2b, Global Multicenter Cohort Trial to Assess the Safety and Efficacy of Zipalertinib in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Exon 20 Insertion and Uncommon/Single or Compound Epidermal Growth Factor Receptor Mutations. |
| Erkrankung |
Thorax:
Nicht-kleinzelliges Lungenkarzinom:
Alle Linien
|
| Molekularer Marker |
EGFR EGFR ex20ins |
| Kurzprotokoll | Kurzprotokoll |
| Links | Weiterführende Informationen (DD) Weiterführende Informationen (NIH) |
erstellt 11.01.2024 Data entry III CCP
geändert 26.07.2024 Data entry III CCP